18 The official date of approval is 1 The available data on authorised Both in our survey and the AISE/EBPF 1 1 2 October 2016. As pre-submissions are products of the MSCAs indicates that survey the industry reported very low advised to be made at least 6 months around 15 BPs containing Clothianidin interest in UA for products falling before, submissions can still be made are currently on the market. These are this PT. Only 17% of the products Clothianidin (in until April. Clothianidin is a candidate understimates as the data of the would apply for UA of which only 10% combination with for substitution. There were no MSCAs are not complete and a would opt for the BPF option. pyriproxyfen) comments received during the public number of MS data was not available consultation and the remark was at this level of detail. published that there are alternative AS which are already approved. 2, 3, 4, 6 The official date of approval is 1 The available data on authorised The AS can be used in 3 PT for which 1 + 1 2 + 1 3 + 2 families October 2016. As pre-submissions are products of the indicates that the industry declared intention to opt family family advised to be made at least 6 months around 800 BPs are currently on the for UA (PT2 in particular but also 3 and before, submissions can still be made market containing glutaraldehyde. Only 4). No interest declared for UA for PT 6 until April. Glutheraldehyde is a very small number (max. 10) has the so far. considered to be a candidate for combination with CMIT/MIT. Up to 60% Glutaraldehyde (in substitution by being a respiratory of these BPs fall under PT02. These combination with sensitiser.Three comments were are underestimates as the data of the CMIT/MIT) received during the public consultation MSCAs are not complete and a of which only one emphasised the number of MS data was not available essentiality of the AS. In the conclusion at this level of detail. it is mentioned that there are other active substances with similar intended uses 18 The official date of approval is 1 July Both in our survey and the AISE/EBPF 0 0 0 2016. As pre-submissions are advised survey the industry reported very low to be made at least 6 months before, interest in UA for products falling under
Clothianidin (in combination with pyriproxyfen) 18 The official date of approval is 1 October 2016. As pre-submissions are advised to be made at least 6 months before, submissions can still be made until April. Clothianidin is a candidate for substitution. There were no comments received during the public consultation and the remark was published that there are alternative AS which are already approved. The available data on authorised products of the MSCAs indicates that around 15 BPs containing Clothianidin are currently on the market. These are understimates as the data of the MSCAs are not complete and a number of MS data was not available at this level of detail. Both in our survey and the AISE/EBPF survey the industry reported very low interest in UA for products falling this PT. Only 17% of the products would apply for UA of which only 10% would opt for the BPF option. 1 1 2 Glutaraldehyde (in combination with CMIT/MIT) 2, 3, 4, 6 The official date of approval is 1 October 2016. As pre-submissions are advised to be made at least 6 months before, submissions can still be made until April. Glutheraldehyde is considered to be a candidate for substitution by being a respiratory sensitiser.Three comments were received during the public consultation of which only one emphasised the essentiality of the AS. In the conclusion it is mentioned that there are other active substances with similar intended uses The available data on authorised products of the indicates that around 800 BPs are currently on the market containing glutaraldehyde. Only a very small number (max. 10) has the combination with CMIT/MIT. Up to 60% of these BPs fall under PT02. These are underestimates as the data of the MSCAs are not complete and a number of MS data was not available at this level of detail. The AS can be used in 3 PT for which the industry declared intention to opt for UA (PT2 in particular but also 3 and 4). No interest declared for UA for PT 6 so far. 1 + 1 family 2 + 1 family 3 + 2 families 18 The official date of approval is 1 July 2016. As pre-submissions are advised to be made at least 6 months before, Both in our survey and the AISE/EBPF survey the industry reported very low interest in UA for products falling under 0 0 0
CA-May16-Doc.7.8%20-%20BPR%20fee%20model%20final%20report.docx